Codes / ICD10CM / C7B.04

C7B.04 Secondary carcinoid tumors of peritoneum

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Secondary carcinoid tumors of peritoneum
  • Also referred to as metastatic neuroendocrine tumors in the peritoneum.

Summary

Secondary carcinoid tumors of the peritoneum are cancerous growths that originate from neuroendocrine cells and have spread to the peritoneum, the lining of the abdominal cavity. These tumors are part of a broader category of neuroendocrine tumors and may disrupt normal abdominal organ function depending on their location and size.

Causes

The primary cause is the metastasis of a carcinoid tumor from another part of the body, often from the gastrointestinal tract or lungs. The exact mechanism involves the detachment of cancer cells from the primary tumor and their transportation through the bloodstream or lymphatic system to the peritoneum.

Risk Factors

  • Having a primary neuroendocrine tumor.
  • Genetic predispositions, such as Multiple Endocrine Neoplasia (MEN) syndromes.
  • Age (more common in older adults).
  • A history of previous cancers or prolonged exposure to certain chemicals or radiation.

Symptoms

Symptoms can vary depending on the hormones produced and the location of the metastasis. Common signs include abdominal pain, bloating, unexplained weight loss, or changes in bowel habits. Systemic symptoms may also occur if the tumor disrupts normal organ function.

Diagnosis

Diagnosis typically involves imaging studies like CT, MRI, or PET scans to detect tumors in the peritoneum. Biopsy of affected tissue may be performed to confirm the presence of neuroendocrine cells and rule out other conditions.

Treatment Options

Treatment depends on the extent of the disease and may include surgery to remove tumors, systemic therapies like somatostatin analogs, or targeted treatments. Palliative care may be used to manage symptoms and improve quality of life.

Prognosis and Follow-Up

Prognosis varies based on the primary tumor type, extent of metastasis, and response to treatment. Regular follow-up with imaging and clinical evaluations is important to monitor for recurrence or progression.

Complications

Complications can include bowel obstruction, ascites (fluid buildup in the abdomen), or hormonal imbalances due to tumor activity. Advanced disease may lead to organ dysfunction or systemic effects.

Lifestyle & Prevention

While prevention of metastasis is not always possible, managing the primary tumor and maintaining overall health may reduce risks. Regular medical check-ups are recommended for those with a history of neuroendocrine tumors.

When to Seek Professional Help

Seek medical attention if you experience persistent abdominal pain, unexplained weight loss, or other concerning symptoms. Early evaluation is important for timely diagnosis and management.

Tips for Medical Coders

When coding for secondary carcinoid tumors of the peritoneum, ensure documentation specifies the metastatic nature and location. Verify that the primary tumor site is documented if available, as this may impact coding accuracy. Use this code (C7B.04) only when the peritoneum is the specified secondary site.

Book a walkthrough

C7B.04 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.